title: Effect of 192 IgG-saporin on circadian activity rhythms, expression of P75 neurotrophin receptors, calbindin-D28K, and light-induced Fos in the suprachiasmatic nucleus in rats.
abstract: Photic entrainment of circadian rhythms in mammals is mediated through a direct retinal projection to the core region of the suprachiasmatic nucleus (SCN), the circadian clock. A proportion of this projection contains the low-affinity p75 neurotrophic receptor (p75NTR). Neonatal monosodium glutamate (MSG) treatment, which dramatically reduces p75NTR immunoreactivity in the SCN has no impact on photic entrainment. In order to clarify the contribution of p75NTR fibers in photic entrainment, targeted lesions of the p75NTR-immunoreactive SCN plexus were performed using intracerebroventricular (ICV) or intrahypothalamic injections of the immunotoxin 192 IgG-saporin (SAP) in rats. SAP treatment effectively abolished p75NTR immunoreactivity within the SCN core. ICV SAP treatment produced three different behavioral activity patterns: Animals became arrhythmic, displayed a shorter free-running period, or remained rhythmic following the lesion. Arrhythmic animals had large hypothalamic lesion which encompassed the entire SCN. In rhythmic rats, ICV-SAP significantly reduced immunostaining for calbindin-D28k (CaBP) in the SCN, and rats with shortened free-running periods had the lowest number of CaBP immunoreactive cells. ICV SAP also attenuated light-induced Fos expression in the SCN core. Despite lack of p75NTR and reduced CaBP and Fos expression in the SCN, SAP-treated rhythmic rats displayed normal photic entrainment. Intrahypothalamic SAP treatment reduced CaBP expression in the SCN but had no effect on light-induced Fos expression, free-running rhythms, or photic entrainment. The data show that p75NTR-immunoreactive elements in the SCN are not required for photic entrainment.
mesh_terms: D000204:Activity Cycles / Q000187:drug effects / Q000528:radiation effects; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D064092:Calbindin 1; D064026:Calbindins; D002940:Circadian Rhythm / Q000187:drug effects* / Q000528:radiation effects; D004333:Drug Administration Routes; D007150:Immunohistochemistry; D000922:Immunotoxins / Q000494:pharmacology*; D008027:Light; D008297:Male; D009043:Motor Activity / Q000187:drug effects / Q000528:radiation effects; D009699:N-Glycosyl Hydrolases; D016761:Oncogene Proteins v-fos / Q000378:metabolism*; D017440:Photoperiod; D051381:Rats; D017208:Rats, Wistar; D020800:Receptor, Nerve Growth Factor; D017475:Receptors, Nerve Growth Factor / Q000096:biosynthesis*; D054789:Ribosome Inactivating Proteins, Type 1; D064030:S100 Calcium Binding Protein G / Q000096:biosynthesis*; D000076985:Saporins; D013493:Suprachiasmatic Nucleus / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism*
chemical_list: C085696:192 IgG-saporin; D000911:Antibodies, Monoclonal; C576500:Calb1 protein, rat; D064092:Calbindin 1; D064026:Calbindins; D000922:Immunotoxins; D016761:Oncogene Proteins v-fos; D020800:Receptor, Nerve Growth Factor; D017475:Receptors, Nerve Growth Factor; D054789:Ribosome Inactivating Proteins, Type 1; D064030:S100 Calcium Binding Protein G; D009699:N-Glycosyl Hydrolases; D000076985:Saporins